期刊
CANCERS
卷 13, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/cancers13102500
关键词
tumor-targeting mAb; memory NK cells; vaccinal effect; IFNγ CD16; ADCC; combinatory immunotherapeutic approach
类别
资金
- Sapienza Universita' di Roma, Progetti di Ateneo [RG1181641E17D02C, RM11916B7A62655E]
NK cells play a crucial role in cancer immunotherapy based on tumor-targeting monoclonal antibodies by interacting with IgG-opsonized tumor cells through the CD16 receptor. Activated NK cells not only exert cytotoxic functions but also produce a range of cytokines and chemokines to enhance adaptive immune responses. Strategies aiming to enhance NK cell-mediated antitumor functions in tumor-targeting monoclonal antibody regimens include mAb manipulation strategies and the potential exploitation of memory NK cells with unique characteristics.
Simple Summary Natural Killer (NK) cells play a major role in cancer immunotherapy based on tumor-targeting mAbs. NK cell-mediated tumor cell killing and cytokine secretion are powerfully stimulated upon interaction with IgG-opsonized tumor cells, through the aggregation of Fc gamma RIIIA/CD16 IgG receptor. Advances in basic and translational NK cell biology have led to the development of strategies that, by improving mAb-dependent antitumor responses, may overcome the current limitations of antibody therapy attributable to tolerance, immunosuppressive microenvironment, and genotypic factors. This review provides an overview of the immunotherapeutic strategies being pursued to improve the efficacy of mAb-induced NK antitumor activity. The exploitation of antibody combinations, antibody-based molecules, used alone or combined with adoptive NK cell therapy, will be uncovered. Within the landscape of NK cell heterogeneity, we stress the role of memory NK cells as promising effectors in the next generation of immunotherapy with the aim to obtain long-lasting tumor control. Natural killer (NK) cells hold a pivotal role in tumor-targeting monoclonal antibody (mAb)-based activity due to the expression of CD16, the low-affinity receptor for IgG. Indeed, beyond exerting cytotoxic function, activated NK cells also produce an array of cytokines and chemokines, through which they interface with and potentiate adaptive immune responses. Thus, CD16-activated NK cells can concur to mAb-dependent vaccinal effect, i.e., the development of antigen-specific responses, which may be highly relevant in maintaining long-term protection of treated patients. On this basis, the review will focus on strategies aimed at potentiating NK cell-mediated antitumor functions in tumor-targeting mAb-based regimens, represented by (a) mAb manipulation strategies, aimed at augmenting recruitment and efficacy of NK cells, such as Fc-engineering, and the design of bi- or trispecific NK cell engagers and (b) the possible exploitation of memory NK cells, whose distinctive characteristics (enhanced responsiveness to CD16 engagement, longevity, and intrinsic resistance to the immunosuppressive microenvironment) may maximize therapeutic mAb antitumor efficacy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据